Supernus Pharmaceuticals (SUPN) Retained Earnings (2011 - 2026)
Supernus Pharmaceuticals' Retained Earnings came in at $457.21 million for Q2 2026, down 19.4% from $567.1 million a year earlier and down 11.3% from the prior quarter.
Powered by 
Analysis
Supernus Pharmaceuticals (SUPN) Retained Earnings (2011 - 2026) Analysis & Trends
At the end of FY2025, Supernus Pharmaceuticals' Retained Earnings was $517.88 million, down 6.9% from FY2024.
- Retained Earnings carries a five-year compound annual growth rate of 9.7% (FY2020 to FY2025).
- Going back by year, Retained Earnings was $556.43 million in FY2024 (+15.3%), $482.56 million in FY2023 (+0.3%), $481.25 million in FY2022 (+26.7%) and $379.92 million in FY2021 (+16.4%).
- The Q2 2026 figure represents the lowest quarterly Retained Earnings since Q3 2022.
- Year-over-year, Retained Earnings has declined for four consecutive quarters, with growth averaging 2.3% over the last eight quarters.
- The fastest year-over-year change in Retained Earnings over five years came in Q1 2022 (growth of 34.3%), and the weakest in Q2 2026 (a decline of 19.4%).
- Business Quant data shows SUPN's Retained Earnings at $515.58 million (Q1 2026), $517.88 million (Q4 2025) and $521.98 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 171.67 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | -17.33 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 63.27 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 40.86 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 12.59 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | -22.28 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 2.20 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 112.09 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 15.69 Bn |
| 10 | Supernus Pharmaceuticals | 2.56 Bn | 1.21 Bn | 185.39 Mn | 457.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 457.21 Mn |
| Mar 31, 2026 | 515.58 Mn |
| Dec 31, 2025 | 517.88 Mn |
| Sep 30, 2025 | 521.98 Mn |
| Jun 30, 2025 | 567.10 Mn |
| Mar 31, 2025 | 544.60 Mn |
| Dec 31, 2024 | 556.43 Mn |
| Sep 30, 2024 | 541.10 Mn |
| Jun 30, 2024 | 502.60 Mn |
| Mar 31, 2024 | 482.69 Mn |
| Dec 31, 2023 | 482.56 Mn |
| Sep 30, 2023 | 481.39 Mn |
| Jun 30, 2023 | 497.36 Mn |
| Mar 31, 2023 | 498.19 Mn |
| Dec 31, 2022 | 481.25 Mn |
| Sep 30, 2022 | 455.76 Mn |
| Jun 30, 2022 | 454.02 Mn |
| Mar 31, 2022 | 446.15 Mn |
| Dec 31, 2021 | 379.92 Mn |
| Sep 30, 2021 | 377.48 Mn |
API Access
Supernus Pharmaceuticals Retained Earnings API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=retained-earnings&ticker=SUPN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "retained-earnings", "ticker": "SUPN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=retained-earnings&ticker=SUPN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();